A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS

Clinical trial NCT04517253 · TERMINATED

Trial details

NCT number: NCT04517253
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Nakajo-Nishimura Syndrome Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome STING-Associated Vasculopathy With Onset in Infancy Aicardi Goutieres Syndrome

Start date: 2020-10-27
Primary completion: 2023-04-04
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.